MedPath

282 MEP TAB

282 MEP TAB

Discontinued
DIN Number

00108316

Drug Class

Human

Market Date

Dec 31, 1959

Company
HC

merck frosst canada & cie, merck frosst canada & co.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00108316
AIG Number0401071001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02BA71 ACETYLSALICYLIC ACID, COMB WITH PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (4)

ACETYLSALICYLIC ACIDActive
Strength: 350 MG
Monograph: ACETYLSALICYLIC ACID
CAFFEINE CITRATEActive
Strength: 30 MG
Monograph: CAFFEINE CITRATE
CODEINE PHOSPHATEActive
Strength: 15 MG
Monograph: CODEINE PHOSPHATE
MEPROBAMATEActive
Strength: 200 MG
Monograph: MEPROBAMATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.